⌘K

Login Start Free

Home/Filings/4/0001144204-14-015272

4//SEC Filing

ENDOCYTE INC 4

Accession 0001144204-14-015272

CIK 0001235007operating

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 7:31 PM ET

Size

10.3 KB

Accession

0001144204-14-015272

Insider Transaction Report

Form 4

Period: 2014-03-10

ENDOCYTE INCECYT

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
2014-03-10$1.91/sh+80,000$152,800→ 204,586 total
Exercise/Conversion
Stock Option (right to buy)
2014-03-10−58,733→ 19,060 total
Exercise: $1.91Exp: 2016-08-31→ Common Stock (58,733 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-03-10−21,267→ 0 total
Exercise: $1.91Exp: 2016-02-17→ Common Stock (21,267 underlying)
Gift
Common Stock
2014-02-21−2,400→ 124,586 total

Footnotes (1)

[F1]The option is fully vested and immediately exercisable.

Documents

1 file

4
v371462_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001235007

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 7:31 PM ET
Size: 10.3 KB

View on SEC.gov